SureTrader
Interactive Brokers Advertisement
SureTrader
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board: 
Last Post: 6/27/2017 8:32:07 PM - Followers: 1337 - Board type: Free - Posts Today: 24

Biotech Values is a forum for discussing 
all facets of biotech investing with an emphasis
on fundamental analysis and avoiding scams.
We generally do not discuss microcap stocks.

Calendars and Compilations
Webcasts
FDA Calendar
Recent Biotech Buyouts

Buyouts of Biotech Partners
Common Biotech-Newbie Mistakes
Biotech Holdings of Selected Institutional Investors
US Patent Expirations for Big-Selling Biologics
Biotech and Miscellaneous Acronyms

Top Twitter Feeds for Biotech Info
iHub's Greatest Hits (thru 5/09)

PostSubject
#212139  Sticky Note BLUE sells—(upsized)—4.38M* shares @$105.00—a 5.5% discount to yesterday’s DewDiligence 06/27/17 08:25:16 PM
#212135  Sticky Note CHRS 30% workforce reduction: DewDiligence 06/27/17 04:21:28 PM
#212121  Sticky Note ALDR > down 23%...Alder's migraine drug data disappoints, biocqr 06/27/17 09:02:13 AM
#212119  Sticky Note SGYP - Seeking Alpha - Ironwood's Future Outlook iandy 06/27/17 07:55:31 AM
#212115  Sticky Note (MNTA)—CHRS’ Humira-FoB study you posted has switching from DewDiligence 06/26/17 09:44:35 PM
#212107  Sticky Note CHRS BLA for Humira FoB delayed to 1H18 DewDiligence 06/26/17 04:26:01 PM
#212141   PRTO thx for the follow up Dew. Whalatane 06/27/17 08:32:07 PM
#212140   RGEN sells 3.23M* shares @$42.75—a 6% discount to DewDiligence 06/27/17 08:30:02 PM
#212139   BLUE sells—(upsized)—4.38M* shares @$105.00—a 5.5% discount to yesterday’s DewDiligence 06/27/17 08:25:16 PM
#212138   PTRO—...does this imply some conviction by these large DewDiligence 06/27/17 08:13:16 PM
#212137   PRTO Thx Dew ...so does this Whalatane 06/27/17 07:10:39 PM
#212136   MNTA bold prediction: DewDiligence 06/27/17 05:05:14 PM
#212135   CHRS 30% workforce reduction: DewDiligence 06/27/17 04:21:28 PM
#212134   Webcast Calendar ghmm 06/27/17 03:33:01 PM
#212133   RARX -19% on phase-2 data in PNH: DewDiligence 06/27/17 01:40:12 PM
#212132   House Republicans backed this biotech — and lost biocqr 06/27/17 12:04:15 PM
#212130   It seems fully valued, IMO. I doubt that DewDiligence 06/27/17 11:43:01 AM
#212129   Does anyone have an opinion on NEOS? ronpopeil 06/27/17 11:38:20 AM
#212128   (TEVA)—XENE -20% on phase-2 failure in PHN: DewDiligence 06/27/17 11:07:42 AM
#212127   PRTO—The convertible preferred stock is a workaround to DewDiligence 06/27/17 10:20:04 AM
#212126   MRK will be concerned overall re AMRN's Reduce-It north40000 06/27/17 10:05:46 AM
#212125   LBIO—>IOVA (Iovance Biotherapeutics): DewDiligence 06/27/17 10:03:50 AM
#212124   NEOS sells 5.52M* shares @$6.75—an 8% discount to DewDiligence 06/27/17 09:59:54 AM
#212123   MRK’s Anacetrapib CVOT hits primary endpoint, but… DewDiligence 06/27/17 09:50:22 AM
#212122   IIL.AX -92%(!) on phase-2b failure in SPMS: DewDiligence 06/27/17 09:44:21 AM
#212121   ALDR > down 23%...Alder's migraine drug data disappoints, biocqr 06/27/17 09:02:13 AM
#212120   a product won’t be eligible for FDA interchangeable zipjet 06/27/17 08:47:19 AM
#212119   SGYP - Seeking Alpha - Ironwood's Future Outlook iandy 06/27/17 07:55:31 AM
#212118   PRTO Dew could you offer an opinion Whalatane 06/27/17 12:11:32 AM
#212117   MNTA—Isn't the fear (hope) that the FDA will DewDiligence 06/26/17 10:03:40 PM
#212116   Isn't the fear (hope) that the FDA will MadCityCyclone 06/26/17 09:46:43 PM
#212115   (MNTA)—CHRS’ Humira-FoB study you posted has switching from DewDiligence 06/26/17 09:44:35 PM
#212114   ATXI IPOs 6.33M* shares @$6:00: DewDiligence 06/26/17 09:36:27 PM
#212112   First of all we'll have to see what jbog 06/26/17 07:54:20 PM
#212111   SELB > up 12% today on $50M private placement... biocqr 06/26/17 07:23:45 PM
#212110   When the "before" and "after" photos a company rkrw 06/26/17 06:01:23 PM
#212109   IPIX (formerly Cellceutix) up big today on breathless GrthzGd 06/26/17 04:38:34 PM
#212108   BLUE selling $402.5M(!)* of stock on unspecified terms: DewDiligence 06/26/17 04:32:58 PM
#212107   CHRS BLA for Humira FoB delayed to 1H18 DewDiligence 06/26/17 04:26:01 PM
#212106   That remains to be seen; however, companies other DewDiligence 06/26/17 04:18:07 PM
#212105   So Dew, there is no one but mnta linhdtu 06/26/17 04:07:14 PM
#212104   The primary endpoint for the trial as defined jellybean 06/26/17 03:05:59 PM
#212103   MNTA—Reiterating FDA comment on interchangeable FoBs: DewDiligence 06/26/17 02:43:37 PM
#212102   SVA—This buyout is the kind of risk I DewDiligence 06/26/17 02:06:34 PM
#212101   also regarding $srpt, the truth is coming out masterlongevity 06/26/17 01:59:28 PM
#212100   Re: SGEN ciotera 06/26/17 12:38:26 PM
#212099   I assume they ran scenarios and $2.5B was nowlurking 06/26/17 12:32:48 PM
#212098   I doubt that AGN ends up getting $2.5B DewDiligence 06/26/17 10:57:35 AM
#212097   An acquaintance was quite happy with the results nowlurking 06/26/17 10:29:20 AM
#212096   MTNB -30% on phase-2 failure in vulvovaginal candidiasis: DewDiligence 06/26/17 10:04:14 AM
#212095   OSE.PA -24% on enrollment pause in phase-3 NSCLC DewDiligence 06/26/17 10:01:15 AM
#212094   SGEN -10% on positive phase-3 in first-line HL DewDiligence 06/26/17 09:57:23 AM
#212093   NEOT -70% on failed phase-2 in “double-chin” fat: DewDiligence 06/26/17 09:48:34 AM
#212092   All these boring inconclusive studies are marching swampboots 06/26/17 09:40:18 AM
#212091   ENTA reports preclinical data on EDP-938 RSV inhibitor; DewDiligence 06/26/17 09:00:45 AM
#212090   What about their PPMO program? They have talked iwfal 06/26/17 08:53:33 AM
PostSubject